Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA-NCI roundtable symposium

Landgren Ola; Gormley Nicole; Turley Danielle; Owen Roger G.; Rawstron Andy; Paiva Bruno; Barnett David; Arroz Maria; Wallace Paul; Durie Brian; Yuan Constance; Dogan Ahmet; Stetler-Stevenson Maryalice; Marti Gerald E.

首页> 外文期刊>American Journal of Hematology >Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA-NCI roundtable symposium

【24h】

Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA-NCI roundtable symposium

机译：流式细胞术检测多发性骨髓瘤最小残留病：FDA-NCI圆桌会议的经验教训

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《American Journal of Hematology》 |2014年第12期|共2页
作者
Landgren Ola; Gormley Nicole; Turley Danielle; Owen Roger G.; Rawstron Andy; Paiva Bruno; Barnett David; Arroz Maria; Wallace Paul; Durie Brian; Yuan Constance; Dogan Ahmet; Stetler-Stevenson Maryalice; Marti Gerald E.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA-NCI roundtable symposium [J] . Landgren Ola, Gormley Nicole, Turley Danielle, American Journal of Hematology . 2014,第12期

机译：流式细胞术检测多发性骨髓瘤最小残留病：FDA-NCI圆桌会议的经验教训
2. Comparison of minimal residual disease detection in multiple myeloma by SRL 8-color single-tube and EuroFlow 8-color 2-tube multiparameter flow cytometry [J] . Takamatsu Hiroyuki, Yoroidaka Takeshi, Fujisawa Momoko, International journal of hematology . 2019,第4期

机译：SRL 8型单管和Euroflow 8色2管多次骨髓瘤最小残留疾病检测的比较
3. Comparison of Minimal Residual Disease Detection in Autografts of Patients with Multiple Myeloma between 8-Color Multiparameter Flow Cytometry (EuroFlow) and Next-Generation Sequencing [J] . Takamatsu Hiroyuki, Takezako Naoki, Wee Rachel K., Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：8色多次髓瘤患者自体移植患者的最小残留疾病检测比较（EUROFLOW）和下一代测序
4. Measuring Minimal Residual Disease in Multiple Myeloma by LC-MS/MS; A Comparison to Multicolor Flow Cytometry [C] . H. Robert Bergen, Angela Dispenzieri, Surendra Dasari, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：通过LC-MS / MS测量多发性骨髓瘤中的最小残留疾病;与多色流式细胞术的比较
5. Detection and Monitoring of Multiple Myeloma Measurable Residual Disease by High Sensitivity Flow Cytometry [D] . Soh, Kah Teong. 2020

机译：高灵敏度流式细胞术检测和监测多发性骨髓瘤可测量的残留疾病
6. Impact of Minimal Residual Disease Detection by Next-Generation Flow Cytometry in Multiple Myeloma Patients with Sustained Complete Remission after Frontline Therapy [O] . Evangelos Terpos, Ioannis V. Kostopoulos, Efstathios Kastritis, 2019

机译：新一代流式细胞术检测最小残留疾病对一线治疗后持续完全缓解的多发性骨髓瘤患者的影响
7. Impact of Minimal Residual Disease Detection by Next-Generation Flow Cytometry in Multiple Myeloma Patients with Sustained Complete Remission after Frontline Therapy [O] . Evangelos Terpos, Ioannis V. Kostopoulos, Efstathios Kastritis, 2019

机译：下一代流式细胞术在多个骨髓瘤患者中持续完全缓解前的下一代流式细胞术对持续完全缓解的影响

Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA-NCI roundtable symposium

著录项

相似文献

相关主题

期刊订阅